Real-time US stock option implied volatility surface analysis and expected move calculations for trading strategies and risk management. We use options pricing models to derive market expectations for stock movement over different time periods and expiration dates. We provide IV analysis, expected move calculations, and volatility surface modeling for comprehensive coverage. Understand option market expectations with our comprehensive IV analysis and move calculation tools for options trading.
Coherus Oncology Inc. (CHRS) is a clinical-stage oncology biotech firm whose shares are currently trading at $2.0, marking a 0.76% gain in recent trading. This analysis examines key technical levels, prevailing market context for the stock and its peer group, and potential near-term price scenarios based on current trading patterns. As a small-cap healthcare stock, CHRS is subject to higher volatility than many large-cap equities, with price movements often driven by a mix of sector sentiment, c
Is Coherus (CHRS) stock losing upward momentum (Bullish Sentiment) 2026-04-20 - Market Buzz Alerts
CHRS - Stock Analysis
4349 Comments
1096 Likes
1
Greydon
Experienced Member
2 hours ago
As a detail-oriented person, this bothers me.
👍 286
Reply
2
Lucretia
Senior Contributor
5 hours ago
Who else is here just watching quietly?
👍 193
Reply
3
Cheena
Active Contributor
1 day ago
Comprehensive US stock balance sheet stress testing and liquidity analysis for downside risk assessment. We model different scenarios to understand how companies would perform under adverse conditions.
👍 42
Reply
4
Zvi
Power User
1 day ago
Indices are hovering near key resistance levels, which could serve as decision points for traders.
👍 18
Reply
5
Evolett
Consistent User
2 days ago
This feels like something important happened.
👍 285
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.